Workshop

Pre-Conference Symposium:

Developments in Biodefense and Pandemic Influenza Vaccines & Therapeutics

June 9, 2008 | 8:00 a.m. - 5:00 p.m.

A Briefing from Leading Researchers on the Latest R&D.

As a prelude to the conference, the Symposium will provide attendees an update on the research and development efforts underway for biodefense and pandemic influenza vaccines and therapeutics. The symposium provides an excellent opportunity to hear from leading researchers from government, academia and industry about the critical advances being made.

Instructors:

Chairs:
Michael Callahan, M.D., DTM&H, Program Manager, Defense Science Office, Defense Advanced Research Projects Agency
Peter Hobart, Ph.D., Science Director, U.S. Army Medical Research Institute for Infectious Diseases
Michael Kurilla, M.D., Director, Office of BioDefense Research Affairs and Associate Director for BioDefense, National Institute of Allergy and Infectious Diseases, NIH

Presenters:
Patrick Iversen, Ph.D., Senior Vice President of Research & Development, AVI BioPharma
Tony DeFougerolles, Ph.D., Senior Director of Research, Alnylam Pharmaceuticals
Vishwanath Lingappa, M.D., Ph.D., Chairman of the Board and Chief Technology Officer, Prosetta Corporation
J. Kevin Judice, Ph.D., CEO, Achaogen Inc.
Joseph Shaw, Ph.D., CEO and Chairman, Syntiron Inc.
Barbara Domayne-Hayman, Ph.D., CEO, Stabilitech
Parrish Galliher, Ph.D., Founder and Chief Technology Officer, Xcellerex Inc.
Vidadi Usibov, Ph.D., Fraunhofer Biotechnologies